| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MUS.25102 |
| P698 | PubMed publication ID | 26970407 |
| P50 | author | Matilde Leonardi | Q56936660 |
| P2093 | author name string | Lucia Morandi | |
| Maria Barbara Pasanisi | |||
| Ambra M Giovannetti | |||
| Milda Černiauskaitė | |||
| Chiara Bussolino | |||
| P2860 | cites work | Spinal Muscular Atrophy | Q28080774 |
| Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells | Q28252944 | ||
| Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design | Q28293151 | ||
| Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 | ||
| Using thematic analysis in psychology | Q30476519 | ||
| Developing the World Health Organization Disability Assessment Schedule 2.0 | Q34271065 | ||
| Clinical outcome measures in spinal muscular atrophy | Q37513013 | ||
| Childhood spinal muscular atrophy: controversies and challenges | Q38003742 | ||
| Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy | Q38313528 | ||
| Quality of life and new antipsychotics in schizophrenia. Are patients better off? | Q40776920 | ||
| Integrating response shift into health-related quality of life research: a theoretical model | Q40806505 | ||
| Correlation between severity and SMN protein level in spinal muscular atrophy | Q41102726 | ||
| Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale. | Q43815423 | ||
| Pilot trial of albuterol in spinal muscular atrophy | Q44115110 | ||
| Effect of acute and short-term oral salbutamol treatments on maximal power output in non-asthmatic athletes | Q45300294 | ||
| 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17-19 April 1998, Soestduinen, The Netherlands. | Q53344748 | ||
| Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. | Q53552718 | ||
| P.6.4 Salbutamol tolerability and efficacy in adult type III SMA patients: Results of a multicentric, molecular and clinical, double-blind, placebo-controlled study | Q56688312 | ||
| P433 | issue | 5 | |
| P921 | main subject | rac-salbutamol | Q410358 |
| spinal muscular atrophy | Q580290 | ||
| muscular atrophy | Q2844600 | ||
| P304 | page(s) | 843-849 | |
| P577 | publication date | 2016-03-11 | |
| P1433 | published in | Muscle and Nerve | Q15764281 |
| P1476 | title | Perceived efficacy of salbutamol by persons with spinal muscular atrophy: A mixed methods study | |
| P478 | volume | 54 |
Search more.